Peg-Lasgen(pegaspargase)
Therapeutic class: Antineoplastic
Indication: First Line Acute Lymphoblastic Leukemia (ALL), Acute Lymphoblastic Leukemia And Hypersensitivity To Asparaginase
- 3,750 International Units/5 mL (750 International Units/mL)
- For IM/IV administration
- 2°C to 8°C , Shelf Life: 2 Years
- As directed by the physician
